**Specifications Table**TableSubject areaMedicine, BiologyMore specific subject areaMolecular biology, Cancer ResearchType of dataTable, figureHow data was acquiredPCR, DNA melting analysis with TaqMan probes using CFX96 real-time PCR detection system (Bio-Rad Laboratories, USA)Data formatRaw, analyzedExperimental factorsDNA was isolated from cultured MCF-7 cells and tumor samples (colon and lung cancer).Experimental featuresAsymmetric PCR and multiplex DNA melting analysis with TaqMan probes were used for detection of mutations in *PIK3CA* exons 9 and 20.Data source locationMoscow, Russian FederationData accessibilityData is available with this article

**Value of the data**•*PIK3CA* two primer pairs provide pseudogene-free amplification of two mutation hot spots in exons 9 and 20.•Asymmetric real-time PCR and multiplex melting curve analysis with TaqMan probes are effective in clinical setting for evaluation of the status (wild-type or mutant) of clinically important genes.•This cost-effective method executed in the "closed format" is simple, versatile and sensitive.

1. Data {#s0005}
=======

The multiplex assays with TaqMan probes were carried out to amplify two regions of *PIK3CA* gene (in exons 9 and 20) and analyze the amplicons by DMA for the presence of the "hot spot" mutations (codons 542--546 and 1047--1049, respectively). This short (about 1.5 h) procedure is implemented in the "closed tube" format minimizing the sample cross-contaminations [@bib4].

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. DNA isolation {#s0015}
------------------

DNA was isolated from cultured MCF-7 cells and tumor samples (colon and lung cancer) by phenol--chloroform deproteinization, and from FFPE samples by using the QIAamp DNA FFPE Tissue Kit (Qiagen) as recommended by the manufacturer. DNA concentrations were determined spectrophotometrically (Nano-Drop 1000, Thermo Scientific). DNA samples were stored at −20 °C until needed

2.2. Primer and probe design {#s0020}
----------------------------

Primers and probes used for *PIK3CA* melting curve analysis are presented in [Table 1](#t0005){ref-type="table"}. Designations of the probes include the name of the amplicon (PIK9 or PIK20), fluorophore (ROX or Cy5), length and direction (sense and antisense probes are designated by subscript signs *s* and *as*, respectively). Selection of which of the two strands of the amplicon (sense or antisense) to be a target for a TaqMan probe is important, as follows from the thermodynamic calculations [@bib5], and can affect discrimination between wild type and mutant alleles [@bib1]. The primer set PIK9-f and PIK9-r is designed with two mismatches at the 3′-end of the reverse primer to a highly homologous (98%) chromosome 22 region to discriminate against the pseudogene and avoid false positives [@bib2].

2.3. Sanger sequencing {#s0025}
----------------------

Bi-directional analysis was performed by the fluorescent dideoxynucleotide termination method (Syntol, Moscow, Russia).

2.4. Asymmetric real time PCR and DNA melting analysis {#s0030}
------------------------------------------------------

Amplification reactions were carried out in 96-well plates in CFX96 Real Time PCR detection system (Bio-Rad Laboratories, Hercules, CA). Each 25-µl reaction contained 50 mM Tris--HCl, pH 8.8, 50 mМ KCl, 0.01% (v/v) Tween 20, 3 mM MgCl~2~, 0.25 мМ dNTPs, 1.25 U *Taq* polymerase, a primer pair (0.04 µМ/0.4 µM), 0.2 µM TaqMan probe (Syntol, Moscow), and 5 µl of DNA template. Real Time PCR protocols started with a denaturation step for 5 min at 95 °C, followed by 55 cycles of 95 °C for 13 s, 56 °C for 15 s, 72 °C for 20 s with fluorescence acquisition at 72 °C. After asymmetric PCR, DNA was heated at 95 °C for 1 min and incubated at 50 °C for 2 min, after which it was melted from 50 °C to 82 °C (increment 0.4 °C, dwell time 6 s, rate of heating 3.3 °C/s). The Bio-Rad CFX96 Manager software (version 1.6) was used to collect and analyze amplification and melting data from the CFX96 Real Time PCR detection system.

2.5. PIK3CA mutation scanning {#s0035}
-----------------------------

The assays were used to analyze 19 FFPE samples from patients with colorectal and lung cancer, among which 14 were detected to harbor *PIK3CA* mutations, as confirmed by bi-directional Sanger sequencing ([Table 2](#t0010){ref-type="table"}).

The concordance rate between sequencing and DMA data was 100%. Typical DMA melting peaks for the frequent *PIK3CA* mutations are shown in [Fig. 1](#f0005){ref-type="fig"}.

Appendix A. Supplementary material {#s0045}
==================================

Supplementary material

This work was supported by the N.N. Blokhin Russian Cancer Research Center (grant 10-04-00060).

Supplementary data associated with this article can be found in the online version at [doi:10.1016/j.dib.2015.10.046](http://dx.doi.org/10.1016/j.dib.2015.10.046){#ir0005}.

![Multiplex DMA of *PIK3CA* mutations (exons 9 and 20) with PIK9-ROX(28)~as~ and PIK20-Cy5(23)~s~ probes, respectively. (A) -- wild-type; (В) -- MCF-7 cells (heterozygous mutation in exon 9-GAG545AAG) [@bib2], [@bib3]; (C)-colon cancer (mutation in exon 9); (D) -- colon cancer (mutation in codon 20). Curves 1 and 2 refer to exons 9 and 20, respectively. Mutation types (determined by Sanger sequencing) are shown in figures.](gr1){#f0005}

###### 

Amplicons, primers and probes used for mutation scanning *PIK3CA* by DMA.

Table 1.

  **Amplicon (exon, codons, size)**            **Primers (forward, reverse), probes (sense, antisense)**   **Sequences, sizes**
  -------------------------------------------- ----------------------------------------------------------- ---------------------------------
  **PIK9** (exon 9, c. 542--546, 191 bp)       Primer PIK9-f                                               5'-GGGGAAAAATATGACAAAG (19 b)
  Primer PIK9-r                                5'-CATTTTAGCACTTACCTGTGAC (22 b)                            
  Probe PIK9-ROX(28)~as~                       ROX-CTTTCTCCTGCTCAGTGATTTCAGAGAG-BHQ2 (28 b)                
  **PIK20** (exon 20, c. 1047--1049, 194 bp)   Primer PIK20-f                                              5'-TGATGACATTGCATACATTC (20 bp)
  Primer PIK20-r                               5'-TCCAGAGTGAGCTTTCATT (19 bp)                              
  Probe PIK20-Cy5(23)~s~                       Cy5-ATGATGCACATCATGGTGGCTGG-BHQ2 (23 bp)                    

###### 

Comparison of Sanger sequencing and DMA data for the *PIK3CA* mutations.

Table 2.

  **Gene**   **Sanger sequencing**   **DMA**[a](#tbl2fna){ref-type="table-fn"}
  ---------- ----------------------- -------------------------------------------
  1\.        GAG545AAG               \+
  2\.        GAA542AAA               \+
  3\.        GAG545AAG               \+
  4\.        GAG545AAG               \+
  5\.        GAA542AAA               \+
  6\.        Wild Type               −
  7\.        GAG545AAG               \+
  8\.        GAG545AAG               \+
  9\.        Wild Type               −
  10\.       GAG545AAG               \+
  11\.       GAG545AAG               \+
  12\.       Wild Type               −
  13\.       GAG545AAG               \+
  14\.       GAG545GGG               \+
  15\.       Wild Type               −
  16\.       Wild Type               −
  17\.       CAT1047CGT              \+
  18\.       CAT1047CGT              \+
  19\.       CAT1047CGT              \+

−, wild type; +, mutation detected.
